GLP-1 receptor agonists and the gut-brain axis: what the latest trials are showing
New data from three independent trials suggests the appetite-regulating effects of GLP-1 agonists extend well beyond the stomach. Researchers are now examining downstream effects on dopamine signaling and reward circuitry.